CV
A concise public CV for web viewing, covering education, experience, publication evidence, projects, skills, and languages without private application details.
This is a web-safe short CV for the public website. For a formal application CV with fuller private details, please contact me through Contact or an existing academic thread.
Summary
Chaojie Bu is a psychology-trained digital health builder with completed English-medium psychology study across UK and US higher education systems, cross-cultural academic readiness, hospital-based psychological medicine workflow experience in China, and a public focus on psychological assessment workflows, responsible digital health tools, selected services, public writing, and personal agency.
This is a web-safe short CV for the public website. For a formal application CV with fuller private details, please contact me through Contact or an existing academic thread.
Education
Bangor University
2019-2020
English-medium master's training in psychology, academic writing, independent study, and research communication. Dissertation: Gender and Age Differences in the Recall of Autobiographical Memories Using the Autobiographical Memory Recollection Test. Degree certificate dated 2020-12-01.
Arizona State University
2013-2018
English-medium undergraduate psychology and behavioural science training in the United States. Degree conferred 2018-05-07.
China health-system Intermediate Psychological Therapist qualification within the Chinese health system.
Hospital-based psychological medicine workflow experience in a tertiary hospital in China.
Support for high-volume psychological assessment and routine clinical measurement workflows, including structured report communication and non-diagnostic workflow support.
Assessment exposure includes PHQ-9, GAD-7, HAMD, HAMA, MMPI, and SCL-90 depending on departmental workflow and clinical requirements.
Hands-on experience operating and supporting TMS / neurostimulation, EEG, and fNIRS / near-infrared brain function imaging workflows within departmental protocols.
Patient-reported outcome observation, clinical support communication, clinical service documentation, and research-adjacent data awareness.
Psychological assessment
Routine clinical measurement
Measurement-based care
Patient-reported outcomes
Wellbeing tracking
Behavioural health
Health outcomes
Ageing and rehabilitation contexts
Behaviour change
Clinical outcome observation
TMS / neurostimulation-related outcome observation
Digital mental health
Responsible AI-assisted self-reflection
Implementation usefulness
Engagement, dropout, deterioration, and triage
Interpretable prediction and calibration
Safety, bias, and subgroup audit
Publications
Only verified public citation details are shown.
2023
Clinical and Translational Oncology, 25(5), 1378-1388. DOI: 10.1007/s12094-022-03032-1. PubMed PMID: 36484954.
Verified first-author PubMed-indexed evidence. It is presented as evidence of first-author research capacity and psychology-linked translational clinical research experience, not as a digital mental health validation claim.
2025
Journal of Medical Forum, 46(10), 1039-1042, 1049. DOI: 10.20159/j.cnki.jmf.2025.10.007.
First-author Chinese clinical mental health article from the Australia PhD evidence materials. It is presented as hospital-based clinical mental health research evidence involving PANAS, STAI, HRV, emotional outcomes, and physiological outcome monitoring, not as PubMed-indexed evidence.
2026
Neuro-Oncology Advances. DOI: 10.1093/noajnl/vdag040. PubMed PMID: 41778154.
Co-authored PubMed-indexed clinical/translational record. It is relevant because the article directly connects emotional distress, immune checkpoint blockade efficacy, recurrent high-grade glioma, and clinical outcomes; it is not presented as first-author work.
2026
Cancer, 132(2), e70253. DOI: 10.1002/cncr.70253. PubMed PMID: 41533333.
Co-authored PubMed-indexed randomized phase 2 clinical trial record. It is included as clinical/translational collaboration evidence and is not presented as first-author work.
2025
Neurosurgery, 97(3), 671-680. DOI: 10.1227/neu.0000000000003384. PubMed PMID: 40042315.
Co-authored PubMed-indexed clinical/translational record on postsurgical tumor in situ fluid circulating tumor DNA, recurrence prediction, and clinical benefit evaluation.
2024
Journal of Cancer Research and Clinical Oncology, 150(10), 466. DOI: 10.1007/s00432-024-05997-8. PubMed PMID: 39422764.
Co-authored PubMed-indexed clinical trial record. It is included as evidence of clinical/translational collaboration around recurrent glioblastoma, ctDNA, and treatment-efficacy forecasting.
2023
Frontiers in Oncology, 13, 1238607. DOI: 10.3389/fonc.2023.1238607. PubMed PMID: 37920153.
Selected co-authored PubMed-indexed clinical/translational record. It is included as broader research-collaboration evidence and kept separate from the digital mental health research direction.
2023
iScience, 26(9), 107528. DOI: 10.1016/j.isci.2023.107528. PubMed PMID: 37649695.
Co-authored PubMed-indexed clinical/translational record on glioma distant relapse and molecular evolution; it is not presented as first-author work.
2023
Cancer Medicine, 12(16), 17171-17183. DOI: 10.1002/cam4.6327. PubMed PMID: 37533228.
Co-authored PubMed-indexed clinical/translational record on oligodendroglioma recurrence genomics; it is included as collaboration evidence.
2022
Clinical and Translational Medicine, 12(7), e956. DOI: 10.1002/ctm2.956. PubMed PMID: 35802830.
Co-authored PubMed-indexed clinical/translational record. PubMed classifies it as a letter; it is included conservatively as collaboration evidence.
2021
Clinical and Translational Medicine, 11(11), e567. DOI: 10.1002/ctm2.567. PubMed PMID: 34841677.
Co-authored PubMed-indexed clinical/translational record. PubMed classifies it as a letter; it is included conservatively as collaboration evidence.
2021
Frontiers in Oncology, 11, 742037. DOI: 10.3389/fonc.2021.742037. PubMed PMID: 34712610.
Co-authored PubMed-indexed clinical/translational record on tumor in situ fluid, minimal residual disease, and early recurrence risk after glioma surgery.
Projects
Skills
Experience around structured assessment procedures, report preparation, non-diagnostic communication, and common clinical rating/self-report instruments such as PHQ-9, GAD-7, HAMD, HAMA, MMPI, and SCL-90 within hospital-based psychological medicine settings.
Able to translate assessment and support-process information into clear, bounded language for patients, colleagues, and public-facing materials.
Interested in self-report signals, follow-up structure, wellbeing tracking, PANAS/STAI/HRV-style outcome indicators, and outcome observation that remain conservative about clinical authority.
Hands-on operation/support experience across TMS / neurostimulation, EEG, and fNIRS / near-infrared brain function imaging workflows within departmental protocols.
Uses AI-assisted workflows to prototype non-diagnostic self-reflection tools, privacy pages, support routes, product documentation, and research-facing public infrastructure.
Research interest in calibration, uncertainty communication, subgroup performance, bias review, and preventing user misunderstanding.
Builds static websites, product pages, compliance documentation, and research-facing materials with AI-supported coding and editing workflows.
Designs product structure, onboarding language, privacy boundaries, App Store support infrastructure, and public product positioning.
Can ship static-first Next.js pages, reusable content architecture, SEO metadata, privacy pages, support pages, and deployment-ready frontend systems.
Works across English-first academic/product communication and Chinese professional writing for selected services and public media.
Languages
Academic and professional communication across research, product, and public-facing materials.
Native professional communication for clinical workflow, public writing, and selected services.